What Happens to a Peptide in Your Body?

Most peptides last minutes in your body, not hours or days. A peptide is a short chain of amino acids, and your body treats nearly any such chain as material to be taken apart and cleared away. Two processes go to work on it at the same time. Enzymes cut the chain into pieces, and your kidneys filter small molecules out into your urine. Between them they usually finish long before anything you would call a long time has passed. That surprises people, and it sounds like a fault. It is not. Short life is the point, and the rest of this article is about why.

What a half-life is, and the part most people miss

You will meet the phrase half-life everywhere in this subject, usually with a number attached. It is worth getting exactly right, because it is misread more often than almost any other term here.

A half-life is the time it takes for half of what is present to disappear. That is the entire definition. If something has a half-life of ten minutes, then ten minutes after it arrives, roughly half of it is gone.

Here is the part people miss. The halving does not happen once and stop. It keeps happening, over and over, to whatever is still there. In principle the amount never quite reaches zero. It just becomes too small to matter, and then too small to measure.

• After one half-life: about half of it is still there.
• After two half-lives: about a quarter.
• After three half-lives: about an eighth.
• After four half-lives: about a sixteenth, which is roughly six percent of what you started with.

Two common misreadings fall apart once it is written out like that.

The first is that a half-life is how long something lasts. It is not. Something with a ten-minute half-life is not gone at ten minutes. A real fraction is still there at thirty minutes, and a trace at an hour.

The second is that it leaves at a steady rate. It does not. Far more disappears in the first ten minutes than in the fifth ten minutes, because each round of halving works on a smaller pile than the round before.

An everyday picture helps. Imagine a hundred people in a room, and every ten minutes half of whoever is still inside walks out. Fifty leave in the first ten minutes. Twenty-five leave in the next ten. Then twelve or so, then six. The room empties quickly at the start and trickles for a long while afterward. Peptides behave much the same way.

The two ways your body gets rid of it

Two separate systems take a peptide out of circulation, and they are not doing the same job.

The first is enzymes. An enzyme is a protein whose job is to speed up one particular chemical reaction. A whole family of them does nothing but cut chains of amino acids into shorter pieces. They sit in your blood, in the lining of your blood vessels, in your liver and kidneys, and along the wall of your gut. They cut a chain into fragments, those fragments get cut again, and what is left is loose amino acids your body reuses as ordinary raw material.

The second is your kidneys. Your kidneys filter your blood continuously, and that filter works largely on size. Small things pass through and leave in your urine. Large things stay behind in the blood. Most peptides are small, because being short is what makes a peptide a peptide, so a great many go straight through and out.

The detail that matters is that these two are not steps in a sequence. They run at the same time, on the same molecule, from the moment it arrives.

That is why slowing only one of them accomplishes so little. Picture a bucket with two holes in the bottom. Plug one hole and the bucket still empties through the other. It takes somewhat longer, and that is the whole benefit. Anyone trying to make a peptide last has to deal with both holes.

This is not a design flaw

It is easy to read all of that as a problem, as though the body were being wasteful or working against itself. Turning that around is what makes the whole subject make sense.

Your body makes peptides of its own, and uses many of them as signals: chemical messages sent from one place to tell cells somewhere else what to do. Those signals are built to vanish quickly. Their speed of disappearance is not a limitation nobody got around to fixing. It is a requirement of the job.

Here is why. A message that never goes away is not a message. It is noise.

Insulin is the example nearly everyone has heard of. Insulin is a peptide, released after you eat, when there is sugar in your blood that needs handling. Cells read that signal and pull the sugar out of the blood. Then the sugar is dealt with, insulin release drops off, and what is circulating gets cleared away.

Now imagine insulin stayed in your blood forever. It could tell you nothing about the meal you just ate, because it would be sitting there whether you had eaten or not. Its presence would carry no information. The signal means something only because it rises and then falls.

A doorbell works the same way. A doorbell that rings once tells you somebody is at your front door. A doorbell that rings without stopping tells you nothing, except that it is broken. The silence between rings is what makes a ring worth hearing.

So your body spends real effort taking its own messages apart, on purpose, fast. Short-lived is the normal, working, healthy state for a peptide signal. It is close to the definition of what a signal is.

So how can a medicine last a week?

If peptides vanish in minutes, the obvious question is how a peptide-based medicine works at all. The answer is that enormous effort goes into fighting exactly this, and it has been one of the central problems of the field for decades 1.

Two approaches do most of the work, and both are easier to describe than you might expect.

The first is to change the molecule slightly at the exact place an enzyme would cut it. Enzymes work by recognition: an enzyme grips a particular pattern in the chain and cuts there. Alter that pattern a little and the enzyme no longer recognizes the spot, so it passes by and leaves the chain intact. Think of a key that no longer turns because one notch has been filed down. The rest of the molecule is kept as close to the original as possible, so it still does its job.

The second is to make the peptide stick to something big. Your blood already carries large, long-lived proteins that circulate for weeks. Attach the right kind of tail to a peptide and it will latch on to one of those proteins and travel around attached to it. The kidney's filter now sees something far too large to pass through, so it stays in the blood 3. It comes loose gradually, a little at a time, which stretches its working life out enormously.

That second trick is what makes a once-weekly medication possible at all 4. A peptide that would have been gone within minutes on its own can be made to persist for days.

Both approaches take years of work, and the result is not the same molecule the body makes. It is a deliberately altered version, tested at length to check that the change did not weaken it or introduce something unwanted.

The honest trade-off: you cannot take it back

Making something last longer sounds like an improvement with no downside. It is not.

A molecule that lasts a week cannot be taken back. There is no undo. If something goes wrong, the substance is still there tomorrow, and the day after, and largely still there a week later. Waiting is the only real response available.

With something short-lived, the same trouble is far more contained. It is unpleasant, and then it is over, because the compound itself is gone within the hour. The problem stops because its cause stops.

That is worth holding on to. Short-lived is inconvenient, and it is also, in this one specific way, safer. When you read that a compound has been engineered to last far longer than the natural version, you are reading about a benefit and a cost at once, even when only the benefit gets mentioned.

Where did that number come from?

Half-life figures get quoted with a great deal of confidence, so it helps to know what kind of fact one actually is.

A compound's half-life in a person is measurable. You give a known amount, take blood samples over the following hours, measure how much is present in each one, and work out how fast the amount falls. It is real data from real people, and anyone who repeats the study can check it.

Here is the catch. For most of the peptides sold for research, that study has never been done in humans, or has never been published anywhere a reader can find it 2. The compounds with solid human numbers are overwhelmingly the ones that went through drug development, because that is the process which pays for the measuring.

So when a source states a specific duration for a compound with no human data behind it, that number came from somewhere else. Usually an animal study, where the measurement was real but the animal was not a person. Sometimes an estimate based on the shape of the molecule. Sometimes it has been copied from one page to the next for years, and nobody now knows where it started.

None of that makes the number wrong. An animal measurement is a genuine measurement, and a careful estimate is better than nothing. The difficulty is narrower: a borrowed number arrives in the same confident tone as a measured one, and a reader has no way to tell them apart.

So the useful habit is not suspicion. It is a question. Where did this number come from? Was it measured in people, in mice, or was it calculated? If a source cannot answer that, you have learned something useful about the source, whatever the number turns out to be.

And if the honest answer is that nobody has measured it, which for research peptides is the common answer, then the accurate sentence is that the half-life in humans is unknown. That is a perfectly respectable thing to say, and far more useful than a confident figure with nothing underneath it.